MedPath

BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

HSA:20

Drug Approvals

SOTYKTU FILM-COATED TABLETS 6 MG

Approval Date
Feb 4, 2024
HSA

OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG

Approval Date
Aug 31, 2023
HSA

ZEPOSIA CAPSULES TREATMENT INITIATION PACK

Approval Date
May 17, 2023
HSA

ZEPOSIA CAPSULES 0.92 MG

Approval Date
May 17, 2023
HSA

INREBIC CAPSULES 100 MG

Approval Date
Sep 29, 2022
HSA

ONUREG FILM-COATED TABLETS 200 MG

Approval Date
Aug 19, 2022
HSA

ONUREG FILM-COATED TABLETS 300 MG

Approval Date
Aug 19, 2022
HSA

REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL

Approval Date
Apr 6, 2022
HSA

REBLOZYL POWDER FOR SOLUTION FOR INJECTION 25 MG/VIAL

Approval Date
Apr 6, 2022
HSA

NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

Approval Date
Nov 9, 2016
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.